Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia

Cited by (222)

Items 101–200 of 222

1. A small molecule screen identifies in vivo modulators of peripheral nerve regeneration in zebrafish
   Juliane Bremer, Julianne Skinner, Michael Granato · 2017 · PLoS ONE
2. Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents
   David L. Brautigan, Caroline C. Farrington, Goutham Narla · 2021 · Clinical Science
3. Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer
   David M. Langenau, Alejandro Sweet-Cordero, Robert J. Wechsler‐Reya, Michael A. Dyer · 2015 · Cancer Research
4. Three-dimensional ex vivo co-culture models of the leukaemic bone marrow niche for functional drug testing
   Sukhraj Pal Singh Dhami, Shanthi S. Kappala, Alexander Thompson, Éva Szegezdi · 2016 · Drug Discovery Today
5. Epigenetic Restoration of Fetal-like IGF1 Signaling Inhibits Leukemia Stem Cell Activity
   Vincenzo Giambra, Samuel Gusscott, Deanne Gracias, Raymond Song, Sonya H.L. Lam, Patrizio Panelli, Kateryna Tyshchenko, Catherine E. Jenkins, Catherine Hoofd, Alireza Lorzadeh et al. · 2018 · Cell stem cell
6. Mass spectrometry imaging in zebrafish larvae for assessing drug safety and metabolism
   Mariana Asslan, Nidia Lauzon, Maja Beus, Dušica Maysinger, Simon Rousseau · 2021 · Analytical and Bioanalytical Chemistry
7. Zebrafish Models of Human Leukemia: Technological Advances and Mechanistic Insights
   Nicholas R. Harrison, Fabrice Laroche, Alejandro Gutiérrez, Hui Feng · 2016 · Advances in experimental medicine and biology
8. Transmission of plant viruses in fields through various vectors
   Shyam Singh, L.P. Awasthi, Anjeet Jangre · 2020 · Elsevier eBooks
9. Short-hairpin RNA library: identification of therapeutic partners for gefitinib-resistant non-small cell lung cancer
   Makoto Sudo, Seiichi Mori, Vikas Madan, Henry He Yang, Geraldine Leong, Harold Phillip Koeffler · 2014 · Oncotarget
10. Understanding the regulatory landscape of protein phosphatase 2A (PP2A): Pharmacological modulators and potential therapeutics
    David B. Neale, Jonathan C. Morris, Nicole M. Verrills, Alaina Jean Ammit · 2025 · Pharmacology & Therapeutics
11. From GWAS to drug screening: repurposing antipsychotics for glioblastoma
    Wei-Zhi Lin, Yen‐Chun Liu, Meng-Chang Lee, Chi-Tun Tang, Gwo‐Jang Wu, Yu-Tien Chang, Chi‐Ming Chu, Chia‐Yang Shiau · 2022 · Journal of Translational Medicine
12. Phosphoproteomics Profiling of Nonsmall Cell Lung Cancer Cells Treated with a Novel Phosphatase Activator
    Danica D. Wiredja, Marzieh Ayati, Sahar Mazhar, Jaya Sangodkar, Sean Maxwell, Daniela Schlatzer, Goutham Narla, Mehmet Koyutürk, Mark R. Chance · 2017 · PROTEOMICS
13. How Surrogate and Chemical Genetics in Model Organisms Can Suggest Therapies for Human Genetic Diseases
    Katherine A Strynatka, Michelle C Gurrola-Gal, Jason N. Berman, Christopher R. McMaster · 2018 · Genetics
14. Reeling in the Zebrafish Cancer Models
    Alicia M. McConnell, Haley R. Noonan, Leonard Ira Zon · 2020 · Annual Review of Cancer Biology
15. Chemical Screening in Zebrafish
    Colleen A. Brady, Andrew J. Rennekamp, Randall Theodore Peterson · 2016 · Methods in molecular biology
16. The Greatwall kinase safeguards the genome integrity by affecting the kinome activity in mitosis
    Xavier Bisteau, Joann S Lee, Vinayaka Srinivas, Joanna Lee, Joanna Niska-Blakie, Gifford Tan, Shannon Yap, Kevin W. Hom, Cheng Kit Wong, Jeongjun Chae et al. · 2020 · Oncogene
17. Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma
    Laura V. Bownes, Raoud Marayati, Colin H. Quinn, Andee M. Beierle, Sara Claire Hutchins, Janet Rae Julson, Michael H. Erwin, Jerry E. Stewart, Elizabeth Mroczek‐Musulman, Michael H. J. Ohlmeyer et al. · 2022 · Cancers
18. Antipsychotics possess anti-glioblastoma activity by disrupting lysosomal function and inhibiting oncogenic signaling by stabilizing PTEN
    John Ryan Jacob, Kamalakannan Palanichamy, Arnab Chakravarti · 2024 · Cell Death and Disease
19. What Zebrafish and Nanotechnology Can Offer for Cancer Treatments in the Age of Personalized Medicine
    María Cascallar, Sandra Alijas, Alba Pensado‐López, Abi Judit Vázquez-Ríos, Laura E. Sanchez, Roberto Piñeiro, María de la Fuente · 2022 · Cancers
20. Zebrafish models of leukemia
    Shuning He, Changbin Jing, Alfred Thomas Look · 2017 · Methods in cell biology
21. The Relationship Between MMP-2 -1306C>T and MMP-9 -1562C>T Polymorphisms and the Risk and Prognosis of T-Cell Acute Lymphoblastic Leukemia in a Chinese Population: A Case-Control Study
    Congmeng Lin, Yanling Zeng, Min Xiao, Xuqiao Mei, Lv-Ying Shen, Meng-Xian Guo, Zhe-Yao Lin, Qifa Liu, Yang Tin · 2017 · Cellular Physiology and Biochemistry
22. Loss of function tp53 mutations do not accelerate the onset of myc‐induced T‐cell acute lymphoblastic leukaemia in the zebrafish
    Alejandro Gutiérrez, Hui Feng, Kristen E. Stevenson, Donna S Neuberg, Oscar Calzada, Yi Zhou, David M. Langenau, Alfred Thomas Look · 2014 · British Journal of Haematology
23. The Power of Fish Models to Elucidate Skin Cancer Pathogenesis and Impact the Discovery of New Therapeutic Opportunities
    Sreeja Sarasamma, Yu‐Heng Lai, Sung‐Tzu Liang, Kechun Liu, Chung‐Der Hsiao · 2018 · International Journal of Molecular Sciences
24. The Interplay between PP2A and microRNAs in Leukemia
    Peter P. Ruvolo · 2015 · Frontiers in Oncology
25. Protein Phosphatases—A Touchy Enemy in the Battle Against Glioblastomas: A Review
    Arata Tomiyama, Tatsuya Kobayashi, Kentaro Mori, Koichi Ichimura · 2019 · Cancers
26. Potential of phenothiazines to synergistically block calmodulin and reactivate PP2A in cancer cells
    Ganesh babu Manoharan, Sunday Okutachi, Daniel Abankwa · 2022 · PLoS ONE
27. Progress in research on childhood T-cell acute lymphocytic leukemia, Notch1 signaling pathway, and its inhibitors: A review
    Fangfang Zhong, You Bing Yang, Wenjun Liu · 2020 · Bosnian Journal of Basic Medical Sciences
28. Protein phosphatase 2A controls ongoing DNA replication by binding to and regulating cell division cycle 45 (CDC45)
    Abbey L. Perl, Caitlin M. O’Connor, Pengyan Fa, Franklin Mayca Pozo, Junran Zhang, Youwei Zhang, Goutham Narla · 2019 · Journal of Biological Chemistry
29. Zebrafish models of acute leukemias: Current models and future directions
    Brandon Molina, Jasmine Chavez, Stephanie J. Grainger · 2020 · Wiley Interdisciplinary Reviews Developmental Biology
30. Synergistic combination of perphenazine and temozolomide suppresses patient-derived glioblastoma tumorspheres
    Jun Hong, Ran Joo Choi, Jin‐Kyoung Shim, Kibyeong Kim, Ryong Nam Kim, Hye Joung Cho, Seo Jin Kim, Sohyun Kim, Nam Hwa Kim, Hun Ho Park et al. · 2024 · Neuro-Oncology
31. Advances and Challenges in RAS Signaling Targeted Therapy in Leukemia
    Yu Chen, Zhengfeng Yin, Kenneth D. Westover, Zhiwei Zhou, Liping Shu · 2024 · Molecular Cancer Therapeutics
32. Cytotoxicity of Newly Synthesized Quinazoline–Sulfonamide Derivatives in Human Leukemia Cell Lines and Their Effect on Hematopoiesis in Zebrafish Embryos
    Ali Saeed Alqahtani, Mostafa Mohammed Ghorab, Fahd Ali Nasr, Mohammad Z. Ahmed, Abdullah A. Al-Mishari, Sabry Mohamed Attia, Muhammad Farooq · 2022 · International Journal of Molecular Sciences
33. Bloody Zebrafish: Novel Methods in Normal and Malignant Hematopoiesis
    Emma de Pater, Eirini Trompouki · 2018 · Frontiers in Cell and Developmental Biology
34. Zebrafish as a Platform for Drug Screening
    Tejia Zhang, Randall Theodore Peterson · 2019 · Elsevier eBooks
35. Anti-tumor effects of perphenazine on canine lymphoma
    Shunya Tsuji, Ryotaro Yabe, Tatsuya Usui, Takuya Mizuno, Takashi Ohama, Koichi Sato · 2016 · Journal of Veterinary Medical Science
36. Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational Research
    Shanmuga P. Subbiah, Arin Nam, Natasha Garg, Amita Behal, Prakash Kulkarni, Ravi Salgia · 2020 · Journal of Clinical Medicine
37. Synthesis and Structure of Novel Phenothiazine Derivatives, and Compound Prioritization via In Silico Target Search and Screening for Cytotoxic and Cholinesterase Modulatory Activities in Liver Cancer Cells and In Vivo in Zebrafish
    Mehmet Murat Kışla, Murat Yaman, Fikriye Zengin Karadayı, Büşra Korkmaz, Omer Bayazeid, Amrish Rajendra Kumar, Ravindra Peravali, Damla Gunes, Rafed Said Tiryaki, Emine Gelinci et al. · 2024 · ACS Omega
38. Ligands for Ser/Thr phosphoprotein phosphatases: a patent review (2005-2015)
    Rocío Lajarín-Cuesta, Raquel L. Arribas, Cristóbal de los Rı́os · 2016 · Expert Opinion on Therapeutic Patents
39. Modeling of Chronic Myeloid Leukemia: An Overview of In Vivo Murine and Human Xenograft Models
    Pallavi Sontakke, Jenny Jaques, Edo Vellenga, Jan Jacob Schuringa · 2016 · Stem Cells International
40. Targeting Ca2+ and Mitochondrial Homeostasis by Antipsychotic Thioridazine in Leukemia Cells
    Vivian Moraes, Vivian M. Santos, Eloah Rabello Suarez, Letícia Silva Ferraz, Rayssa de Mello Lopes, Giuliana P. Mognol, Joana D'Arc Campeiro, João Agostinho Machado‐Neto, Fábio Dupart Nascimento, Mirian A.F. Hayashi et al. · 2022 · Life
41. The Pursuit of Enzyme Activation: A Snapshot of the Gold Rush
    Mingxing Teng, Damian W. Young, Zhi Tan · 2022 · Journal of Medicinal Chemistry
42. Human pancreatic cancer patients with Epithelial-to-Mesenchymal Transition and an aggressive phenotype show a disturbed balance in Protein Phosphatase Type 2A expression and functionality
    Jos F. van Pelt, Bob Meeusen, Rita Derua, Liesbeth Guffens, Eric Van Cutsem, Veerle Janssens, Chris Verslype · 2023 · Journal of Translational Medicine
43. Zebrafish Models of Prader-Willi Syndrome: Fast Track to Pharmacotherapeutics
    Emma Dee Spikol, Caroline E. Laverriere, Maya Robnett, Gabriela Carter, Erin M. Wolfe, Eric F. Glasgow · 2016 · Diseases
44. RETRACTED: Skullcapflavone I suppresses proliferation of human lung cancer cells via down-regulating microRNA-21
    Yadong Yang, Ran An, Tao Feng, Xiaofeng Qin, Jian Zhang, Youling Bo, Ben Niu · 2019 · Experimental and Molecular Pathology · Retracted
45. ERα-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer
    Chun-Lin Lin, Xi Tan, Meizhen Chen, Meena Kusi, Chia‐Nung Hung, Chih‐Wei Chou, Ya‐Ting Hsu, Chiou‐Miin Wang, Nameer B. Kirma, Chun‐Liang Chen et al. · 2020 · BMC Medical Genomics
46. Perphenazine exerts antitumor effects on HUT78 cells through Akt dephosphorylation by protein phosphatase 2A
    Shunya Tsuji, Naoki Kohyanagi, Takuya Mizuno, Takashi Ohama, Koichi Sato · 2020 · Oncology Letters
47. Xenopus tropicalis: Joining the Armada in the Fight Against Blood Cancer
    Dionysia Dimitrakopoulou, Dieter Tulkens, Pieter Van Vlierberghe, Kris Vleminckx · 2019 · Frontiers in Physiology
48. A SMAP in the face for cancer
    Shirish Shenolikar · 2017 · Journal of Clinical Investigation
49. Zebrafish B cell acute lymphoblastic leukemia: new findings in an old model
    Gilseung Park, Jessica Burroughs-Garcìa, Clay A. Foster, Ameera Hasan, Chiara Borga, John Kimble Frazer · 2020 · Oncotarget
50. Influence of point mutations on PR65 conformational adaptability: Insights from molecular simulations and nanoaperture optical tweezers
    Anupam Banerjee, Samuel Mathew, Mohsin M. Naqvi, Sema Zeynep Yilmaz, Maria Zacharopoulou, Pemra Doruker, Janet R. Kumita, Shang-Hua Yang, Mert Gür, Laura S. Itzhaki et al. · 2024 · Science Advances
51. CARMIL1-AA selectively inhibits macropinocytosis while sparing autophagy
    Rebecca M. Lim, Alexa Lu, Brennan M. Chuang, Cecily Anaraki, Brandon Chu, Christopher J. Halbrook, Aimee L. Edinger · 2024 · Molecular Biology of the Cell
52. BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemia
    Stephen Jun Fei Chong, Junyan Lu, Rebecca Valentin, Timothy Z. Lehmberg, Jie Qing Eu, Jing Wang, Zhu Fen, Li Ren Kong, Stacey M. Fernandes, Jeremy Zhang et al. · 2025 · Molecular Cancer
53. An okadaic acid fragment analogue prevents nicotine-induced resistance to cisplatin by recovering PP2A activity in non-small cell lung cancer cells
    Raquel L. Arribas, Anna Bordas, Judit Domènech Omella, José Luis Cedillo, Veerle Janssens, Carmen Montiel, Cristóbal de los Rı́os · 2020 · Bioorganic Chemistry
54. Antitumor Activity of PEGylated and TEGylated Phenothiazine Derivatives: Structure–Activity Relationship
    Sandu Cibotaru, Andreea-Isabela Sandu, Alina Florica Nicolescu, Luminita Bajenaru Marin · 2023 · International Journal of Molecular Sciences
55. In Vivo Imaging of Cancer in Zebrafish
    Myron S. Ignatius, Madeline N. Hayes, David M. Langenau · 2016 · Advances in experimental medicine and biology
56. Design, synthesis and anticancer activity of constrained sphingolipid-phenoxazine/phenothiazine hybrid constructs targeting protein phosphatase 2A
    Jean-Baptiste Garsi, Vito Vece, Lorenzo Sernissi, Catherine Auger-Morin, Stephen Hanessian, Alison N. McCracken, Elizabeth M. Selwan, Cuauhtemoc B. Ramirez, Amogha Dahal, Nadine Ben Romdhane et al. · 2019 · Bioorganic & Medicinal Chemistry Letters
57. Zebrafish live imaging: a strong weapon in anticancer drug discovery and development
    Tiancheng Zhan, Wanqian Song, Jing Guo, Yongkang Yuan, Ning Kang, Qiang Zhang · 2024 · Clinical & Translational Oncology
58. Profiling the interactome of protein kinase C ζ by proteomics and bioinformatics
    Chunyu Hou, Yuan Li, Huiqin Liu, Mengjiao Dang, Guoxuan Qin, Ning Zhang, Ruibing Chen · 2018 · Proteome Science
59. Drug Design Progress of in Silico, in Vitro and in Vivo Researches
    Qifeng Bai, Lanlan Li, Shanhui Liu, Shujun Xiao, Yu Guo · 2018
60. Small-molecule modulators of B56-PP2A restore 4E-BP function to suppress eIF4E-dependent translation in cancer cells
    Michelle A. Lum, Kayla A. Jonas, Shreya Parmar, Adrian R. Black, Caitlin M. O’Connor, Stephanie Dobersch, Naomi Yamamoto, Tess M. Robertson, Aidan Schutter, Miranda Giambi et al. · 2025 · Journal of Clinical Investigation
61. Splice of Life for Cancer: Missplicing of PPP2R5A by Mutant SF3B1 Leads to MYC Stabilization and Tumorigenesis
    Caitlin M. O’Connor, Goutham Narla · 2020 · Cancer Discovery
62. Zebrafish
    Jason Rihel, Marcus Ghosh · 2015 · Springer eBooks
63. Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer’s Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy
    Sheng Li, Rajiv Bhalla · 2024 · Neurochemical Research
64. Phosphatase Dysregulation in Cancer: Signaling Pathways and Therapeutic Opportunities
    Maryam Jama, Michael Overduin, Khaled Barakat · 2025 · MedComm – Oncology
65. Tackling Acute Lymphoblastic Leukemia—One Fish at a Time
    Arpan A. Sinha, Gilseung Park, John Kimble Frazer · 2019 · International Journal of Molecular Sciences
66. Cancer stem cell phosphatases
    Majid Momeny, Tiina Arsiola, Jukka K. Westermarck · 2021 · Biochemical Journal
67. Bioluminescent Zebrafish Transplantation Model for Drug Discovery
    Martina Hason, Jovana Jovicic, Ivana Vonkova, Milan Bojic, Theresa Simon-Vermot, Richard Mark White, Petr Bartůněk · 2022 · Frontiers in Pharmacology
68. Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Emphysema
    Brian Soto, Huma Ahmed, Meshach Pillai, Sangmi S. Park, Magdalena A. Ploszaj, Joshua Reece, H. Taluru, Dylan Bobrow, Howard K.Y. Yu, P. Lafortune et al. · 2023 · American Journal of Respiratory Cell and Molecular Biology
69. 2. Adding perphenazine to increase effectiveness of standard glioblastoma chemoirradiation.
    Richard Eric Kast · 2020
70. Sphingosine simultaneously inhibits nuclear import and activates PP2A by binding importins and PPP2R1A
    Vaishali Jayashankar, Peter Kubiniok, Alison N. McCracken, Rebeca G Gentry, Kazumi H Eckenstein, Lorenzo Sernissi, Vito Vece, Jean-Baptiste Garsi, Sarah Y. Valles, Sunhee Jung et al. · 2025 · The EMBO Journal
71. Uncharted Waters: Zebrafish Cancer Models Navigate a Course for Oncogene Discovery
    Craig J. Ceol, Yariv J. Houvras · 2016 · Advances in experimental medicine and biology
72. Protein Phosphatase 2A as a Therapeutic Target in Pulmonary Diseases
    Howard K.Y. Yu, Sahil Zaveri, Zeeshan Sattar, Michael Schaible, Brais Perez Gandara, Anwar Uddin, Lucas R. McGarvey, Michael H. J. Ohlmeyer, Patrick M. Geraghty · 2023 · Medicina
73. Danio rerio: Small Fish Making a Big Splash in Leukemia
    Barbara Squiban, John Kimble Frazer · 2014 · Current Pathobiology Reports
74. Zebrafish as a versatile preclinical model for evaluating nanomedicine in biomedical research: Recent advances and applications
    Hemlata Hemlata, Nandan Murali, Srabaita Roy, Saran Kumar, Ridhima Tandon, Soutik Betal, Shilpi Minocha · 2025 · Journal of Drug Delivery Science and Technology
75. Phenothiazine Derivatives and Their Impact on the Apoptosis Processes: A Review
    Michał Otręba, Łukasz Marek, Piotr Paduszyński, Jerzy Stojko, Anna Rzepecka‐Stojko · 2025 · Journal of Applied Toxicology
76. Pathobiology of Acute Lymphoblastic Leukemia
    Melissa Burns, Scott A. Armstrong, Alejandro Gutiérrez · 2017 · Elsevier eBooks
77. Animal models of T-cell acute lymphoblastic leukemia: mimicking the human disease
    You Qin, Hexiu Su, Jingchao Wang, Jue Jiang, Guoliang Qing, Hudan Liu · 2018 · Journal of Bio-X Research
78. PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells
    Ji Hyeon You, Jaewang Lee, Jong‐Lyel Roh · 2021 · Research Square
79. Sodium butyrate ameliorates renal tubular lipid accumulation through a protein phosphatase 2A/transcription factor EB axis in diabetic nephropathy
    Jiayin Tao, Sinan Ai, Yaoxian Wang, Yuning Liu, Jingwei Zhou, Qingqing Liu, Xu Wang, Danting Li, Xin Li, Lin Wang et al. · 2025 · British Journal of Pharmacology
80. Typical versus atypical antipsychotics: Genotoxicity and cytostaticity testing
    Evangelos Katsioulis, Maria Argyraki, Maria T. Ekonomopoulou, Constantine Mourelatos, Zafiroula Iakovidou‐Kritsi, Dionysios Mourelatos · 2020 · Integrative Cancer Science and Therapeutics
81. Promising Molecular Targets in Pharmacological Therapy for Neuronal Damage in Brain Injury
    Cristóbal de los Rı́os, Lucía Viejo, Victoria Jiménez, Natalia Hernández Juárez, Natália Alves Martins, Jesús Miguel Hernández-Guijo · 2023 · Antioxidants
82. Modeling leukemia with zebrafish (Danio rerio): Towards precision medicine
    Zhen‐Ni Yi, Xiang‐Ke Chen, Alvin Chun‐Hang · 2022 · Experimental Cell Research
83. Alzheimer's Disease and Cancer: Common Targets
    Xueqing Yang, Jinlian Dai, Chenglong Wu, Zongliang Liu · 2023 · Mini-Reviews in Medicinal Chemistry
84. Zebrafish
    Jason Rihel, Marcus Ghosh · 2015 · Springer eBooks
85. Zebrafish as a Novel Pharmacological Screening Model for Drug Discovery and Development Against Hematological Disorders
    Ambica Gadige, Gunturu Narasimha Tanuj, Amit Khurana, Prince Allawadhi, Isha Khurana, Anil Kumar Banothu, Sunitha Thalugula, Ramavath Redya Naik, Kala Kumar Bharani · 2022 · Springer eBooks
86. 3 Dimensional Cell Culture Techniques in Cancer Research
    K. Dhanya, Aditya Menon · 2020 · Springer eBooks
87. Zebrafish as a Versatile Model for Cancer Research
    Shlok Jindal, Prince Allawadhi, Surabhi Sinha, Amit Khurana, Kala Kumar Bharani, P. Gopinath · 2022 · Springer eBooks
88. Zebrafish MYC-Induced Leukemia Models: Unique In Vivo Systems to Study B and T Cell Acute Lymphoblastic Leukemia
    Chiara Borga, John Kimble Frazer · 2019 · International Journal of Hematologic Oncology
89. Phenothiazine Conjugate with Mitochondria-Directed Cationic Compound F16: Synthesis and Cytotoxic Action against Human Breast Carcinoma
    Eldar V. Davletshin, Darya A. Nedopekina, R. R. Khalitova, Mikhail V. Dubinin, Konstantin N. Belosludtsev, Anna Yu. Spivak · 2023
90. Interplay Between Protein Phosphatase 2A (PP2A) and SE Translocation (SET) as Macromolecular Target of Anticancer Compounds: A Combined Computational and Experimental Study
    Giovanni Ribaudo, Mario Angelo Pagano, Margrate Anyanwu, Matteo Giannangeli, Marika Vezzoli, Andrea Visentin, Federica Frezzato, Livio Trentin, Anna Maria Brunati, Alessandra Gianoncelli · 2025 · Macromol—A Journal of Macromolecular Research
91. Small Molecule Activator of Phosphatase PP2A Remodels Scaffold PR65 Structural Dynamics To Promote Holoenzyme Assembly
    Sema Zeynep Yilmaz, Anupam Banerjee, Satyaki Saha, Michael H. J. Ohlmeyer, Reuven Gordon, Laura S. Itzhaki, İvet Bahar, Mert Gür · 2026 · JACS Au
92. PP2A regulation in acute myeloid leukemia: Mechanisms, stem cell biology, and therapeutic implication
    Michael V. Voronkov, Oleg Suslov, Phani Krishna Parcha, Vivek M. Shastri, Jatinder Kaur Lamba · 2026 · ASPET Discovery
93. The Ticking of the Epigenetic Clock: Antipsychotic Drugs in Old Age
    Adonis Sfera, Carolina Pereira Osorio, Luzmin Inderias, Michael A. Cummings · 2016 · Frontiers in Endocrinology
94. Efficient and Regioselective Synthesis of Phenothiazine via Ferric Citrate Catalyzed C-S/C-N Cross-Coupling
    Tonmoy Chitta Das, Syed Aziz Imam Quadri, Mazahar N Farooqui · 2018 · Letters in Organic Chemistry
95. Zebrafish Model for Drug Discovery and Screening
    Shantanu Joshi · 2022 · Springer eBooks
96. Learning from Zebrafish Hematopoiesis
    Mei Wu, Jin Xu, Yiyue Zhang, Zilong Wen · 2023 · Advances in experimental medicine and biology
97. Comparison of the effects of resistance modifiers on prostate cancer, mouse lymphoma and colon cancer cells
    Ákos Csonka · 2016
98. Influence of Point Mutations on PR65 Conformational Adaptability: Insights from Nanoaperture Optical Tweezer Experiments and Molecular Simulations
    İvet Bahar, Anupam Banerjee, Samuel Mathew, Mohsin M. Naqvi, Sema Zeynep Yilmaz, Maria Zachoropoulou, Pemra Doruker, Janet R. Kumita, Shang-Hua Yang, Mert Gür et al. · 2023 · Research Square
99. What value do zebrafish have to anticancer drug discovery?
    Boyuan Xiao, Esther Landesman‐Bollag, Hui Feng · 2024 · Expert Opinion on Drug Discovery
100. Analysis and characterization of chemo- and radiation therapy sensitizing strategies in tumours with focus on effects of phenothiazines on DNA damage response signalling
     Katarzyna Zielinska-Chomej · 2015 · Figshare